Blog

Back to list page

Guest blog: From innovation to impact: transforming type 1 diabetes care

Written by: Dr Jackie Elliott - 16th November 2026

In this thought leadership piece, Dr Jackie Elliott, Clinical Lead for Diabetes at Sheffield Teaching Hospitals, explores how technology, shared learning and building workforce capability can help us improve and redesign diabetes care, making access more equitable and supporting better outcomes for people living with diabetes.

Across Yorkshire and Humber, the Health Innovation Network is supporting trusts to maximise the impact of hybrid closed-loop technology. This is not simply a technology rollout. As clinical lead for this network I want us to take the opportunity to rethink how we deliver type 1 diabetes care so that access is equitable, services are sustainable and the benefits of this technology translate into better outcomes and better lives.

I took over the lead of the insulin pump service in Sheffield in 2013. At that time, much of our work focused on carefully optimising pump profiles using finger-prick glucose readings. Over the years, continuous glucose monitoring transformed the information available to us, allowing us to adjust treatment with far greater insight. Now we have entered another era: continuous glucose monitors communicating directly with algorithms that optimise insulin delivery every few minutes as a closed loop.

That is an extraordinary leap in clinical practice, with so many more people achieving better glucose levels, reducing the risk of diabetes complications, and leading more normal lives. Our challenge now is to make sure its benefits reach as many people living with type 1 diabetes as possible.

The opportunity is substantial, but so are the implementation challenges. Workforce capacity has not increased at the same pace as technological capability. Much of the expertise required to deliver pump and hybrid closed-loop services has been developed from within existing teams, and that learning continues. At the same time, we know that over the coming years some highly experienced pump specialists will retire or move to the next stage of their careers. We therefore need to think differently about how we develop the next generation of diabetes technology expertise.

That means widening the lens beyond traditional professional boundaries. We need to equip more junior colleagues, and people from across the allied health professions as well as medicine, nursing and dietetics, with the knowledge and confidence to contribute to technology-enabled diabetes care. Building capability cannot depend on isolated centres of expertise or a small number of individuals.

This work forms part of a national programme delivered through the Health Innovation Network, bringing together regional networks and the national team to share learning and support the wider adoption and implementation of hybrid closed-loop technology.

At a regional level, we want to create a supportive community in which teams can share what works, but also talk honestly about what has not worked. Understanding what others have tried can prevent teams spending scarce time and energy reinventing the wheel.

Every trust is different. Workforce, pathways, populations and local systems vary, so a solution that works well in one organisation may need adapting elsewhere. But there is also considerable common ground. By sharing ideas, challenges and practical learning, we can build solutions together while retaining the flexibility needed for local circumstances.

We also need to be rigorous about demonstrating value. Successful implementation cannot be measured only by how many people are started on hybrid closed-loop systems. Robust follow-up and outcome measures must be part of the pathway from the outset.  If we focus solely on onboarding, we risk reaching the end of this period of investment without having fully demonstrated the clinical and wider benefits that this technology can deliver. That evidence will be crucial to sustaining confidence and investment in future access.

Ultimately, hybrid closed loop gives us an opportunity not simply to introduce a new device, but to redesign type 1 diabetes services around what people need now and in the future. To do that well, we need an inclusive conversation involving anyone with a passion for type 1 diabetes care: experienced specialists and newer colleagues, different professional groups, services facing different local challenges, and people prepared to share both successes and setbacks.

If we learn together, build workforce capability together and measure what matters, we can turn a remarkable technological advance into a lasting transformation in the lives of people living with type 1 diabetes.

If you would like to find out more about the programme please email hanson.ugbeva@healthinnovationyh.com